FDA Details How Amendments Affect PDUFA Timelines

Drug Industry Daily
A A
The FDA has shed light on how amendments to an NDA, BLA or supplement may affect review timelines established under the 2012 prescription drug user fee program.

To View This Article:

Login

Subscribe To Drug Industry Daily